Novaremed Announces Management Changes
Novaremed AG (Novaremed), a clinical-stage Swiss biopharmaceutical company, announced today that by mutual agreement with the Board of Directors, Dr. Nicholas Draeger has decided to step down as CEO and member of the Board of Directors and will serve as a senior advisor to Novaremed in order to ensure a smooth leadership transition. The search for a full-time successor to Dr. Draeger has been initiated.
Mr. Subhasis Roy, COO, and Dr. Sara Mangialaio, CMO and Head of R&D, will be assuming responsibilities for the company’s day to day operations and all clinical development work, respectively, effective immediately.
Mr. Subhasis Roy has served as the COO of Novaremed since April 2018 and has over 20 years of experience in healthcare investment banking. Prior to Novaremed, Mr. Roy held senior roles at Sirius Healthcare Partners, UBS, HSBC and DKB, among other firms.
Dr. Sara Mangialaio has served as the CMO and Head of R&D at Novaremed since October 2017 and has over 20 years of experience in the pharmaceutical industry. Dr. Mangialaio held senior roles at Actelion and Novartis and has established experience in the planning and execution of clinical trials.
“We’d like to thank Dr. Draeger for his service and contributions to Novaremed. Our entire management team and board remain committed to developing NRD.E1 and to carrying out our global Phase 2b study,” stated Mr. Harry Welten, Chairman of the Board of Directors of Novaremed.
Notes to the Editor:
About Novaremed
Novaremed Ltd. was founded in 2008 in Israel and reincorporated as Novaremed AG in Switzerland late 2017. Novaremed is developing NRD.E1, an orally-active non-opioid small molecule with a new mechanism of action for the treatment of Diabetic Neuropathic Pain (DPN). In a Phase 2a Proof of Concept study, NRD.E1 showed clinically relevant reduction in patient reported pain. Novaremed is currently preparing for a global Phase 2b study in DPN, expected to start in Q2/3 2020. For more information, visit www.novaremed.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190729005621/en/
Contact information
Subhasis Roy, COO
Tel: +41 79 2075715
Email:
subhasis.roy@novaremed.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Wolters Kluwer wins two A-Team Innovation Awards for excellence in integrated regulatory risk and data transformation1.5.2025 11:05:00 EEST | Press release
Wolters Kluwer Financial & Corporate Compliance has been recognized with two prestigious 2025 A-Team Innovation Awards for excellence in integrated regulatory risk, and financial data management. The awards celebrate innovative projects and teams across the vendor and practitioner communities that leverage new and emerging technologies to deliver high-value solutions for financial institutions. "The A-team Innovation Awards underscore our commitment to delivering exceptional solutions and an unparalleled customer experience. Our solutions adeptly combine financial, risk, and regulatory metrics with modular and flexible configuration capabilities, ensuring responsiveness to an evolving landscape," said Jeroen Van Doorsselaere, Vice President, Global Product & Platform Management, Wolters Kluwer Finance, Risk & Regulatory Reporting. "Financial institutions recognize the immense value of our implementation approach and integrated solutions, along with our comprehensive understanding of in
Taizhou Power Supply Company Powers Dachen, China’s First Zero-Carbon Island, to Showcase the Future of Clean Energy1.5.2025 11:04:00 EEST | Press release
The Taizhou Power Supply Company, a subsidiary of State Grid Zhejiang Electric Power Company, is proud to announce the successful transformation of Dachen Island into China’s first zero-carbon island. Dachen is a living demonstration of what a fully green-powered community can look like—from electric cooking and lighting to renewable-powered industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430231800/en/ Tourists on China’s First Zero-Carbon Island, Dachen Island, to experience the sustainable living. Located 29 nautical miles off the coast of Taizhou in Zhejiang Province, Dachen consists of two islets—Upper and Lower Dachen. Though the island is a two-hour boat ride from the mainland, it’s at the forefront of China’s green energy transformation. Once a test site for early wind turbines, Dachen now operates some of the world’s most advanced energy technologies, including a pioneering 20 Hz flexible low-frequency
Taizhou Power Supply Company Turns Dachen Island Into China’s First Zero-Carbon Island, Pioneering Sustainable Living1.5.2025 10:51:00 EEST | Press release
Taizhou Power Supply Company announced that Dachen Island, situated 29 nautical miles east of Taizhou City in East China’s Zhejiang Province, has officially become China’s first zero-carbon island. From cooking meals to lighting homes, every aspect of life on the island is now powered entirely by renewable wind energy—making it a national pioneer in sustainable living. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430611022/en/ Tourists on China’s First Zero-Carbon Island, Dachen Island, to experience the sustainable living. Historically known as the testing ground for China’s first-generation wind turbines, Dachen Island has evolved into a shining example of green innovation. Through a series of cutting-edge technologies and infrastructure upgrades, the island has successfully achieved zero carbon emissions, embodying China’s broader aspirations for a greener future. Mao Haiming, manager of Haichao Homestay on Dachen Is
OPEX® Sure Sort® X with Xtract™ Automated Sorting, Retrieval and Delivery System Wins Prestigious International Red Dot Award for Product Design1.5.2025 10:00:00 EEST | Press release
OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, is proud to announce its Sure Sort® X with Xtract™ automated sorting, retrieval and delivery system has been recognized with the prestigious Red Dot Award: Product Design 2025. The annual Red Dot Award design competition is regarded as one of the best-known and largest in the world, with winners selected by an international panel of experts who follow the credo, "In search of good design." This marks the second consecutive year OPEX has received the Red Dot Award, recognized in 2024 for its Infinity® automated storage and retrieval system (AS/RS). "We are deeply honored to receive the Red Dot Award: Product Design 2025 for our Sure Sort X with Xtract system," said Alex Stevens, President of Warehouse Automation, OPEX. "For 50 years, OPEX has been developing innovative, unique solutions to help our clients solve their most significant business chal
IFF Completes Divestiture of Pharma Solutions Business Unit1.5.2025 09:00:00 EEST | Press release
IFF (NYSE: IFF) today announced that it has successfully completed the previously announced divestiture of its Pharma Solutions business unit to Roquette. “The completion of our Pharma Solutions divestiture represents a significant milestone for IFF as we delivered our targeted net debt to credit-adjusted EBITDA of below 3.0x,” said Erik Fyrwald, IFF CEO. “This is an important step as it allows us to focus on our core strategy – capitalizing on the exciting growth opportunities within our key businesses – as we maximize long-term value for our shareholders. We’d like to thank our Pharma Solutions colleagues for their unwavering commitment and their dedication to exceptional customer service. We wish them continued success as they find a new home with Roquette.” Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom